Self‐assembled Lipid Nanoparticles for Killing Triple Negative Breast Cancer Cells
Chemistry – An Asian Journal · 02.01.2025 · 20 (1)
DOI: 10.1002/asia.202401049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 26.11.2024. Verfasst von Wahida Rahaman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, Nadia, West Bengal, 741246, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Nanoparticles, Antineoplastic Agents, Polyethylene Glycols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Triple negative breast cancers (TNBCs) lacking estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) on their cell surfaces are highly aggressive, difficult‐to‐treat and often relapse. Herein, we report on the self‐assembled lipid nanoparticles (LNPs) of two new pegylated lipopeptides for killing TNBCs (MDA‐MB‐231). The pegylated lipopeptides were synthesized by conjugating an n‐hexadecyl hydrophobic tail to one end of a (PEG) 27 unit the other distal end of which was covalently grafted with two previously reported tumor targeting RGDK‐ and CGKRK‐ peptides. The SEM images of the self‐assembled LNPs formed upon dissolution of the pegylated lipopeptides in aqueous medium revealed formation of spherical aggregates. The degree of cellular uptake for the self‐assembled LNPs formed by the pegylated CGKRK‐lipopeptide were found to be significantly higher than that for the self‐assembled LNPs formed by the pegylated RGDK‐lipopeptide in MCF‐7, MDA‐MB‐231, HEK‐293 and HFF cells. Notably, about 60 % TNBCs (MDA‐MB‐231 cells) were killed upon treatment with commercially available potent JAK2 inhibitor (WP 1066) loaded LNPs of the pegylated RGDK‐lipopeptide. Contrastingly, the same treatment killed only about 20 % non‐cancerous HEK‐293 cells. The self‐assembled pegylated LNPs described herein open the door for undertaking preclinical studies in animal models for TNBCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, Nadia, West Bengal, 741246, India.
ORCID-Profile: Arabinda Chaudhuri
Förderung
- Indian Council of Medical Research
Zitieren
APA
Rahaman, W., & Chaudhuri, A. (2025). Self‐assembled Lipid Nanoparticles for Killing Triple Negative Breast Cancer Cells. Chemistry – An Asian Journal, 20(1). https://doi.org/10.1002/asia.202401049
Vancouver
Rahaman W, Chaudhuri A. Self‐assembled Lipid Nanoparticles for Killing Triple Negative Breast Cancer Cells. Chemistry – An Asian Journal. 2025;20(1). doi:10.1002/asia.202401049
BibTeX
@article{Rahaman2025,
author = {Rahaman, Wahida and Chaudhuri, Arabinda},
title = {Self‐assembled Lipid Nanoparticles for Killing Triple Negative Breast Cancer Cells},
journal = {Chemistry – An Asian Journal},
year = {2025},
volume = {20},
number = {1},
doi = {10.1002/asia.202401049}
}
EUVIMED